Summary

  • Lumentum agreed to an initial US$43.5 million deposit within 30 business days of its 26 July capacity-reservation agreement with AXT. A second US$43.5 million deposit is contemplated, but its timing and surrounding terms are to be determined during 2028.
  • The deposits are credits against future InP wafer shipments. If Lumentum buys below its annual commitment, it can owe the shortfall; if AXT fails to deliver and does not cure, unused deposit can be refunded; if Lumentum exits for convenience or changed demand, AXT can retain unallocated amounts.
  • Lumentum ended June with US$2.4 billion of purchase obligations, US$691.6 million of inventory and US$451.3 million of annual capex. Those balances predate this agreement. They show a buyer already scaling optical supply, not that the new US$87 million headline is cash paid, wafers received or revenue earned.

Two equal numbers occupy different contractual states

On 26 July, Lumentum Operations and AXT entered a capacity-reservation agreement for indium-phosphide wafer substrates. AXT's filing describes a six-year reservation and possible one-year renewals. In return, Lumentum agreed to two deposits of US$43.5 million.

It is tempting to compress that sentence into an US$87 million purchase. That would erase the most useful information in the disclosure. The first deposit is due within 30 business days of entry. For the second, the timing and the terms surrounding payment are to be determined during calendar 2028. Equal nominal amounts therefore sit on different clocks. One is a current contractual payment test. The other is a later negotiation or specification test whose full state is not yet public.

The term has a similar disclosure edge. The Form 8-K says the reservation runs for six years beginning when the agreement was signed. AXT's attached press release says it runs through 31 December 2031. Those descriptions do not produce exactly the same endpoint from a 26 July 2026 start. The full agreement is due to be filed with AXT's September-quarter report. Until then, the disciplined conclusion is that a long reservation exists while its exact terminal boundary still needs confirmation.

This is not pedantry. The second deposit date, the capacity schedule and the end of the reservation determine when cash, product and remedies can collide. A six-month difference can matter when a buyer is qualifying components for a product generation and a supplier is installing long-lived capacity.

A deposit travels through three ledgers before it becomes an economic result

AXT says both deposits will be applied as credits when covered products are shipped. That makes the conversion path clear. Cash may move first. AXT records an obligation to provide product or otherwise settle the contract. Lumentum later receives wafers and applies credits. AXT recognizes revenue when product control transfers under its accounting policy. Lumentum classifies the delivered material according to its own use and accounting.

The public filings do not yet show the first deposit's receipt or its final classification on either balance sheet. They certainly do not show US$87 million of Lumentum inventory. The second amount has no present payment schedule, and no source says either amount bought a fixed number of wafers on signing day.

The distinction is visible in AXT's quarter-end accounts. At 30 June, before the Lumentum agreement, AXT had approximately US$98.5 million of remaining performance obligations under long-term supply arrangements. Those contracts required about US$47.7 million of advance payments, of which roughly US$12.7 million had arrived. Current contract liabilities were US$12.1 million and long-term contract liabilities about US$1.9 million.

Those balances are not a preview that can simply absorb Lumentum. They belong to an earlier date and existing agreements. AXT's subsequent Lumentum reservation will need its own entry and reconciliation. The next useful disclosure is not a larger combined headline; it is the amount received, the liability or other classification, the remaining deposit credit and the shipments that consume it.

Refund rights divide failure by cause

The agreement does more than move payment forward. It assigns consequences to different reasons why forecast and delivery might diverge.

Lumentum has an annual purchase commitment tied to the reserved Product Capacity. If actual purchases fall below that level, it is responsible for the shortfall, subject to exceptions that AXT summarized around force majeure, quality and non-conformance. If AXT fails to deliver minimum annual capacity and does not cure, it must refund the unused applicable deposit. If Lumentum terminates for convenience or because demand changes, AXT retains unallocated deposit amounts.

These are not interchangeable exit clauses. A weak optical market is not the same event as defective wafers. A supplier delivery miss is not the same as a buyer redesign. A policy interruption may fall under a different exception from ordinary production underperformance. The economic owner of the loss depends on the cause, the cure record and the exact terms that are still redacted.

A refund also repairs only one dimension. It can return unused money. It cannot automatically replace qualification time, a missed product window or scarce output at another supplier. Conversely, AXT's right to retain an unused amount can compensate capacity held away from other customers, but it does not prove the factory incurred an equal cost.

Product Capacity may be changed only by a writing executed by both parties. That preserves a useful authority boundary: a rolling forecast, a customer call or an optimistic market presentation does not silently rewrite the committed quantity.

Lumentum entered the reservation while supply was already allocating demand

The buyer's fiscal-year filing explains why a long substrate right can matter. Lumentum said demand from AI and cloud customers was outpacing current supply and forcing allocation decisions. It was expanding manufacturing capacity internally and through contract manufacturers. Its optical products connect accelerators, servers, storage and switches, so substrate availability sits several stages upstream of a completed module and a working data-centre link.

Fiscal-2026 net revenue rose to US$3.014 billion from US$1.645 billion. Components contributed US$2.006 billion, or 66.5%, while systems contributed US$1.008 billion. The company ended the year with US$2.044 billion of cash and US$694.9 million of short-term investments. This is not a buyer making a deposit because it lacks liquidity.

It is, however, a buyer already carrying a large conversion task. Inventory rose to US$691.6 million from US$470.1 million, and the cash-flow bridge shows a US$228.4 million inventory build. Capital expenditure was US$451.3 million. Accounts receivable also expanded as revenue grew. Operating cash flow reached US$751.4 million, partly supported by a US$221.6 million increase in accounts payable.

The AXT deposit belongs beside those movements, not on top of them. Reserved input has to become qualified components, then products, then receivables and cash. A strong demand statement can justify securing supply, but it cannot prove that every additional wafer will move through that chain at the current margin.

Lumentum's US$2.4 billion of purchase obligations at 27 June were generally expected to be fulfilled within one year. The filing also said open purchase orders may permit cancellation, rescheduling or adjustment. The later AXT agreement is different by design: it reaches well beyond that snapshot and attaches deposit consequences to annual capacity. The June obligation balance therefore cannot be used as though it already contained July's long reservation.

AXT has demand evidence, but the capacity receipt is still ahead

AXT entered this agreement from a much smaller operating base. Second-quarter revenue was US$47.6 million, including US$37.6 million of substrate revenue. Quarterly operating income was US$10.4 million and net income attributable to AXT was US$11.1 million. Management described record InP revenue and rising optical and AI-infrastructure demand.

The balance sheet complicates any claim that customer deposits alone finance expansion. At June, AXT held US$412.2 million of cash, US$5.0 million of short-term investments and US$298.6 million of long-term investments. First-half equity issuance supplied US$602.1 million net. PP&E was US$174.9 million, while first-half purchases of PP&E were US$8.6 million.

The reservation may improve demand visibility and support investment decisions. The disclosed summary does not restrict Lumentum's deposits to a named furnace, prove the reserved capacity has been installed or show the capital needed to deliver it. The receipt must be physical: equipment, qualified process, yield, accepted output and on-time delivery.

AXT's other recent customer contracts reinforce why each advance needs its own label. Casela agreed to prepay an approximately US$25.4 million 2027 purchase programme with an 80% threshold. Coherent agreed to a US$22.3 million prepayment for three years of 6-inch InP development and capacity, with a different refund structure. Adding those amounts to Lumentum produces about US$134.7 million of nominal advances and deposits, but not one balance. Dates, refundability, quantities and performance conditions differ.

Contractual priority does not control the export route

AXT manufactures its wafer substrates in China. Its filing says permits are required for InP exports and offers no assurance that future permits will be granted. Lumentum separately says Chinese restrictions have affected its substrate supply chain globally.

That boundary matters because the contract can allocate risk between buyer and supplier but cannot command a sovereign authority. A deposit may secure priority in AXT's production plan. It does not itself move a wafer through an export licence, customs, logistics, incoming quality control and product qualification.

The most robust supply strategy therefore keeps three records joined without treating them as one: the legal right to capacity, the operational right to export and deliver, and the technical evidence that material meets the required specification. Losing any one can stop conversion even when the other two remain intact.

Sources